Search Results

Improving the Outcome of Bad-Acting Hormone Receptor-Positive Breast Cancer.

• Authors : Gradishar, William J.

Subjects: HORMONE receptor positive breast cancer; BREAST cancer; EPIDERMAL growth factor receptors

• Source: New England Journal of Medicine. 10/31/2024, Vol. 391 Issue 17, p1644-1647. 4p.

Record details

Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials.

Subjects: HORMONE receptor positive breast cancer; HORMONE therapy; RANDOMIZED controlled trials

• Source: Lancet. Oct2024, Vol. 404 Issue 10461, p1407-1418. 12p.

Record details

Pathology of breast cancer metastasis and a view of metastasis to the brain.

• Authors : Sakibuzzaman, Md (AUTHOR); Mahmud, Shahriar (AUTHOR); Afroze, Tanzina (AUTHOR)

Subjects: METASTATIC breast cancer; HORMONE receptor positive breast cancer; BRAIN metastasis

• Source: International Journal of Neuroscience. May2023, Vol. 133 Issue 5, p544-554. 11p.

Record details

Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database.

• Authors : Balatico, Michael¹; Ruano, Ana L.¹; Cleary, Allison S.¹

Subjects: *CANCER invasiveness; *HORMONE receptor positive breast cancer; *CANCER patients

• Source: Archives of Pathology & Laboratory Medicine. Mar2024, Vol. 148 Issue 3, p263-264. 2p.

Record details

The role of trust in the acceptance of adjuvant endocrine therapy in breast cancer patients.

• Authors : Constanze, Elfgen (AUTHOR); Uwe, Güth (AUTHOR); Christoph, Tausch (AUTHOR)

Subjects: TRUST; HORMONE receptor positive breast cancer; HORMONE therapy

• Source: Psycho-Oncology. Dec2022, Vol. 31 Issue 12, p2122-2131. 10p. 3 Charts, 1 Graph.

Record details

Why is it important to define high risk of recurrence in early breast cancer?

• Authors : Mazilu, Laura¹; Popescu, Carmen²

Subjects: *HORMONE receptor positive breast cancer; *BREAST cancer; *MEDICAL personnel

• Source: Oncolog-Hematolog. 2023, Issue 65, p24-25. 2p.

Record details

3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.

• Authors : Pérez-García, José Manuel (AUTHOR); Cortés, Javier (AUTHOR); Ruiz-Borrego, Manuel (AUTHOR)

Subjects: F. Hoffmann-La Roche Ltd.; HORMONE receptor positive breast cancer; HER2 positive breast cancer

• Source: Lancet. 4/27/2024, Vol. 403 Issue 10437, p1649-1659. 11p.

Record details

Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30 , 6097–6110.

• Authors : Alvarado-Miranda, Alberto¹ (AUTHOR); Lara-Medina, Fernando Ulises¹ (AUTHOR); Muñoz-Montaño, Wendy R.¹ (AUTHOR)

Subjects: *HORMONE receptor positive breast cancer; *METASTATIC breast cancer; *PROGESTERONE receptors

• Source: Current Oncology. Nov2024, Vol. 31 Issue 11, p7177-7179. 3p.

Record details

The convergence of genomic medicine and translational omics in transforming breast cancer patient care.

• Authors : Wu, Sulin¹; Yonglan Zheng^1,2; Olopade, Olufunmilayo I.^1,2

Subjects: *HORMONE receptor positive breast cancer; *CANCER patient care; *BREAST cancer

• Source: Journal of Clinical Investigation. 11/1/2024, Vol. 134 Issue 21, p1-3. 3p.

Record details

Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.

• Authors : Chen, Wendy Y.; Ballman, Karla V.; Partridge, Ann H.

Subjects: HORMONE receptor positive breast cancer; BREAST cancer; ASPIRINCANADA

• Source: JAMA: Journal of the American Medical Association. 5/28/2024, Vol. 331 Issue 20, p1714-1721. 8p.

Record details